Sign inCreate account

Report workspace tools

NCT04193267UNKNOWNanonymous

rTMS for the Improvement of Language Functioning in the Logopenic Variant of Primary Progressive Aphasia; a Feasibility and Tolerability Pilot Study

Sponsor

Source record

University of Manitoba

Phase

Source record

NA

Modality

AI-normalized

medical device

Target

AI-normalized

MagStim Rapid2 Transcranial Magnetic Simulation

Indication / condition

AI-normalized

Logopenic Progressive Aphasia

Intervention

Source record

MagStim Rapid2 Transcranial Magnetic Simulation

Source & freshness

Source record

NCT ID

NCT04193267

Original source

ClinicalTrials.gov

Source last updated

Mar 22, 2021

Ingested at

Jun 11, 2026

Internal sync

Jun 11, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT04193267

Title

rTMS for the Improvement of Language Functioning in the Logopenic Variant of Primary Progressive Aphasia; a Feasibility and Tolerability Pilot Study

Sponsor

University of Manitoba

Status

UNKNOWN

Phase

NA

Condition raw

Logopenic Progressive Aphasia

Condition normalized

Logopenic Progressive Aphasia

Modality raw

medical device

Modality normalized

medical device

Target raw

MagStim Rapid2 Transcranial Magnetic Simulation

Target normalized

MagStim Rapid2 Transcranial Magnetic Simulation

Interventions

MagStim Rapid2 Transcranial Magnetic Simulation

Public preview

Source record

The purpose of this study is to investigate the feasibility of using repetitive transcranial magnetic stimulation (rTMS) - a form of non-invasive brain stimulation - to improve language functioning in individuals who have the logopenic variant of primary progressive aphasia (PPA-L) - a slowly progressive impairment of language, characterized by difficulties with word-finding, sentence repetition and sentence comprehension.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

rTMS for the Improvement of Language Functioning in the Logopenic Variant of Primary Progressive Aphasia; a Feasibility and Tolerability Pilot Study

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT04193267

Status

UNKNOWN

Phase

NA

Sponsor

University of Manitoba

Executive brief

Investment-Ready Snapshot

The purpose of this study is to investigate the feasibility of using repetitive transcranial magnetic stimulation (rTMS) - a form of non-invasive brain stimulation - to improve language functioning in individuals who have the logopenic variant of primary progressive aphasia (PPA-L) - a slowly progressive impairment of language, characterized by difficulties with word-finding, sentence repetition and sentence comprehension.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedMar 22, 2021
Internal syncJun 11, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT04193267

Indication

Logopenic Progressive Aphasia

Modality

medical device

Target

MagStim Rapid2 Transcranial Magnetic Simulation

Intervention

MagStim Rapid2 Transcranial Magnetic Simulation

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.